secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2025-05-19T23:59:59+00:00
Accession:  0001140361-25-019786
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AMA expands CPT codes for SSKN's XTRAC laser; now covers vitiligo, atopic dermatitis, alopecia
--------------------------------------------------------------------------------

- AMA CPT Editorial Panel revised codes 96920-96922 to include inflammatory/autoimmune skin diseases beyond psoriasis.
- Expanded coverage unlocks up to 30M potential patients (vs. 10M psoriasis-only), including 3M vitiligo, 16.5M atopic dermatitis patients.
- Expected to reduce systemic denials and prior authorizations; non-psoriasis treatments were ~30% of 2023 Medicare volume.
- CEO Dr. Rafaeli calls it an 'inflection point' for XTRAC; company expects accelerated revenue growth and broader clinic adoption.
- STRATA collaborated with leading dermatologists (Dr. Lebwohl, Dr. Grimes, Dr. Richard) on the CPT change application.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036125019786/0001140361-25-019786-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036125019786/ef20049282_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-019786

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer